Modern Diagnostic & Research Centre Analyzed
The stock of Modern Diagnostic & Research Centre (MDRC) has had a mixed start on the stock market after its initial public offering (IPO). It’s currently trading at Rs 96, which is higher than the price it was offered at (Rs 90). This means investors are paying a little extra for the stock – 6.67% more than when it was first sold.
Key Points
- MDRC stock is trading at Rs 96, a 6.67% premium.
- It’s up 10.56% from the IPO price of Rs 90.
- The stock is down 3.52% since its initial listing.
- 20.91 lakh shares changed hands in the first trading day.
- The IPO was heavily subscribed, 350.49 times.
- Funds raised from anchor investors: Rs 10.45 crore.
The IPO was a big success, with investors wanting to buy a lot of shares. A total of 41 lakh shares were offered for sale, and all of them were snapped up. The company raised around Rs 10.45 crore from big investors before the IPO even started.
MDRC is a well-known company in India that provides lots of different medical tests. They have labs and centers across 8 states and offer services like MRI scans, CT scans, and blood tests. They’re trying to use the money they raised to buy new equipment and expand their operations.
The company employs 616 people and made a good profit – Rs 2.99 crore – in the last six months. They plan to grow by building new labs and centers and offering more specialized services. This growth could make the stock even more valuable in the future.
“The initial market reception suggests investor confidence in Modern Diagnostic & Research Centre’s growth potential and strategic initiatives.”
